SCHEMBL6986193

SCHEMBL6986193

NCC(Cl)(Cc1ccccc1)Cc1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 3/20 0.48
SLC6A2 P23975 1/20 0.48
LOXL2 Q9Y4K0 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.43
HIF1A Q16665 1/20 0.43
CYP2A6 P11509 1/20 0.42
HTR2A P28223 1/20 0.42
CYP1A2 P05177 2/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
KIF11 P52732 3/20 0.41
CYP2D6 P10635 2/20 0.41
CYP3A4 P08684 1/20 0.41
PRMT1 Q99873 1/20 0.41
LMNA P02545 1/20 0.40
MAOA P21397 3/20 0.39
MAOB P27338 2/20 0.39
TSHR P16473 1/20 0.39
AOC3 Q16853 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL27811778 0.98 TAAR1 (0.46) TAAR1SLC6A2LOXL2SMN1; SMN2HIF1A
Phosphine SCHEMBL11016680 0.82 SLC6A2 (0.48) TAAR1SLC6A2LOXL2SMN1; SMN2HIF1A
SCHEMBL15901702 0.76 TAAR1 (0.44) TAAR1SLC6A2LOXL2SMN1; SMN2HIF1A
SCHEMBL21879997 0.75 TAAR1 (0.52) TAAR1SLC6A2LOXL2SMN1; SMN2HIF1A
SCHEMBL9746335 0.75 TAAR1 (0.52) TAAR1SLC6A2LOXL2SMN1; SMN2HIF1A
SCHEMBL3879564 0.75 TAAR1 (0.58) TAAR1SLC6A2LOXL2SMN1; SMN2HIF1A
SCHEMBL324079 0.74 SLC6A2 (0.50) TAAR1SLC6A2LOXL2SMN1; SMN2HIF1A
Hydrochloric Acid SCHEMBL5091679 0.73 TAAR1 (0.50) TAAR1SLC6A2LOXL2SMN1; SMN2HIF1A
Bromide SCHEMBL5085121 0.73 TAAR1 (0.50) TAAR1SLC6A2LOXL2SMN1; SMN2HIF1A
SCHEMBL29342 0.73 TAAR1 (0.56) TAAR1SLC6A2LOXL2SMN1; SMN2HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1206262-A4 NPY ANTAGONISTS: SPIROISOQUINOLINONE DERIVATIVES BRISTOL MYERS SQUIBB CO (US) 2003-01-02 EP disclosed
EP-1206262-A1 NPY ANTAGONISTS: SPIROISOQUINOLINONE DERIVATIVES Bristol-Myers Squibb Company (US) 2002-05-22 EP disclosed
WO-2001013917-A1 NPY ANTAGONISTS: SPIROISOQUINOLINONE DERIVATIVES BRISTOL-MYERS SQUIBB COMPANY (US) 2001-03-01 WO disclosed
EP-1056744-A1 6,9-DISUBSTITUTED 2- TRANS-(4- AMINOCYCLOHEXYL) AMINO]PURINES Aventis Pharmaceuticals Inc. (US) 2000-12-06 EP disclosed
WO-1999043675-A1 6,9-DISUBSTITUTED 2-[TRANS-(4- AMINOCYCLOHEXYL) AMINO]PURINES AVENTIS PHARMACEUTICALS INC. (US) 1999-09-02 WO disclosed